Regulation of ABC membrane transporters in glial cells: Relevance to the pharmacotherapy of brain HIV‐1 infection
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Limited drug penetration is an obstacle that is often encountered in the treatment of CNS diseases including human immunodeficiency virus type‐1 (HIV‐1) encephalitis (HIVE). One mechanism that may contribute to this phenomenon is the expression of ATP‐binding cassette (ABC) drug efflux transporters [i.e., P‐glycoprotein (P‐gp), Multidrug Resistance‐Associated Proteins (MRP/Mrp), Breast Cancer Resistance Protein (BCRP; also known as ABCG2)] at the primary brain barrier sites (i.e., blood‐brain barrier, blood‐cerebrospinal fluid barrier). In addition, it has been recently proposed that glial cells may also contribute to the low accumulation and altered distribution of therapeutic compounds in the CNS by functioning as a “secondary barrier.” In fact, a few studies have shown that ABC transporters are both expressed and functional in glial cells. Furthermore, commonly prescribed antiretroviral compounds (ARVs), particularly HIV‐1 protease inhibitors, are substrates for many of these same transport proteins suggesting that ABC transporters in glial cells may contribute to the overall export of these drugs from the brain. HIV‐1 infection is a chronic condition characterized by long‐term exposure of brain cellular compartments to HIV‐1 virions and soluble viral proteins. In addition, treatment of HIV‐1 infection involves long‐term administration of a multiplicity of ARVs (i.e., HAART regimens). Indeed, pathological factors associated with HIV‐1 infection and/or pharmacological factors related to treatment may alter the expression of ABC transporters and lead to changes in CNS ARV uptake and/or distribution. This review summarizes recent knowledge in this area and emphasizes the role that glial ABC transporters may play in regulating ARV transport. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037 · cited 2×
“Since 1992, when the first MRP/Mrp family members were cloned and characterized (Cole et al., 1992), several anticancer drugs have been identified to be MRP/Mrp substrates including vincristine (MRP1, MRP2, MRP6), etoposide (MRP1-3, MRP6), methotrexate (MRP1-3), daunorubicin (MRP1-2), and cisplatin…”
BackgroundUpdated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630 · cited 3×
“ANI includes HIV-1 seropositive individuals that have demonstrable cognitive impairment that does not affect their daily functioning, whereas MND is a disorder characterized by significant cognitive impairment with mild interference in day-to-day living (Antinori et al., 2007).”
BackgroundChen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
A family of drug transporters: the multidrug resistance-associated proteins
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1295 · Cited by 1,751 · cited 4×
“The mammalian MRP family (humans, MRP; rodents, Mrp) belongs to the ABCC group of proteins, which contains 13 members including one ion channel (i.e., CFTR), two surface receptors (i.e., SUR1 and 2), and a truncated protein that does not mediate transport (ABCC13) (Borst et al., 2000; Dallas et al., 2006).”
BackgroundInfluentialRegulation of transcription by MAP kinase cascades
Treisman, R. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80067-6 · Cited by 1,296
Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J., et al. (2001) · Nature Neuroscience · doi:10.1038/89490 · Cited by 1,102
Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Persidsky, Y., Ramirez, S. H., Haorah, J., & Kanmogne, G. D. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9025-3 · Cited by 922 · cited 2×
“This correlates with monocyte infiltration into the brain (Persidsky et al., 2006) and is accompanied by upregulation of adhesion molecules on brain endothelium (Nottet et al., 1996).”
BackgroundSelf-citationKast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109326200 · Cited by 916 · cited 8×
“Mrp1, MRP4/Mrp4, and Mrp5 have been detected at the choroid plexus (Choudhuri et al., 2003; Rao et al., 1999) while the expression of MRP2/Mrp2 (Choudhuri et al., 2003) and MRP3/Mrp3 (Choudhuri et al., 2003; Nies et al., 2004) at the BCSF barrier is negligible.”
BackgroundInfluentialLevy, D. E., & Lee, C.-K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215650 · Cited by 734
Active nuclear import of human immunodeficiency virus type 1 preintegration complexes.
Bukrinsky, M. I., Sharova, N., Dempsey, M. P., Stanwick, T. L., Bukrinskaya, A. G., Haggerty, S., & Stevenson, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6580 · Cited by 607 · cited 2×
“The preintegration complex must translocate the nuclear envelope before it can present proviral DNA for integration (Bukrinsky et al., 1992), a process that may be aided by the”
Background
Cited by
Abdullahi, W., Tripathi, D., & Ronaldson, P. T. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00095.2018 · Cited by 613
Self-citationNanotechnological advances for the delivery of cns therapeutics.
Wong, H. L., Wu, X. Y., & Bendayan, R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.007 · Cited by 488
Self-citationThe blood-brain barrier in neuroimmunology: Tales of separation and assimilation
Banks, W. A. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.08.007 · Cited by 292
Calcium signaling and gliotransmission in normal vs. reactive astrocytes
Agulhon, C., Sun, M.-Y., Murphy, T., Myers, T., Lauderdale, K., & Fiacco, T. A. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00139 · Cited by 167
“Tetanus toxin would also presumably affect: (i) the transport of multidrug resistance protein 4 (MRP4) – a PGE2 export pump – to the membrane (Reid et al., 2003; Proux-Gillardeaux et al., 2005; Ronaldson et al., 2008) which could alter PGE2 release; or (ii) exocytosis of cytokine vesicular carriers which could decreas…”
BackgroundAshraf, T., Jiang, W., Hoque, M. T., Henderson, J., Wu, C., & Bendayan, R. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-91 · Cited by 40
Self-citationWu, X., Pei, J., Xiong, L., Ge, Q., Bao, P., Liang, C., Yan, P., & Guo, X. (2025) · BMC Genomics · doi:10.1186/s12864-025-11328-z · Cited by 10
“ATP Binding Cassette Subfamily C Member 4(ABCC4) is a member of the ATP-binding cassette (ABC) superfamily transporters, which is involved in cellular defense against oxidative stress [59].”
Antiretroviral Protease Inhibitors Accelerate Glutathione Export from Viable Cultured Rat Neurons
Brandmann, M., Hohnholt, M. C., Petters, C., & Dringen, R. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1284-4 · Cited by 7
Metadata
- Authors
- Ronaldson, P. T., Persidsky, Y., & Bendayan, R.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2008-07-22
- Volume
- 56
- Issue
- 16
- Pages
- 1711-1735
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2003183247
- Cited by
- 90
- References
- 16
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.